Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 12:32 AM
Ignite Modification Date: 2025-12-25 @ 12:32 AM
NCT ID: NCT06312267
Eligibility Criteria: Inclusion Criteria: 1. Elective diverticular, benign polyp, or colon cancer resection 2. Age 18-90 years old 3. All patients must receive some kind of bowel prep (SU- prep, pills, Go-Lytely, milk of magnesia, etc.…) 4. Must be off antibiotics for more than 2 weeks before surgery 5. Surgery must be laparoscopic, hand assisted or Robotic 6. Skin will be closed in layers and subcuticular interrupted fashion 7. Just one dose of preoperative antibiotics (Invanz or equivalent if patient is allergic) 8. Patients will have a primary anastomosis, no colostomy. 9. Patient must be compliant with dressing care 10. Ability to provide informed consent Exclusion Criteria: 1. Active infections before surgery -example: Intra-abdominal abscess not drained or actively on antibiotics on the day of surgery, skin infections 2. Inability to take intestinal bowel preparation 3. HgbA1c \>8 4. BMI \>40 5. Immunosuppression 6. Need of steroid stress dose pre-op 7. Patient receiving active chemotherapy 8. Need of stoma (end ostomies after resection protective stoma included) 9. Need of blood transfusion during surgery 10. Use of irrigation with antibiotics or IRRISEPTR during surgery 11. Any standard contraindication to anesthesia and/or surgery 12. Pregnancy or lactating women 13. Inability to provide informed consent 14. Inability to follow instructions for dressing care 15. Sensitivity or allergy to silver or zinc
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 90 Years
Study: NCT06312267
Study Brief:
Protocol Section: NCT06312267